• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因组编辑对肌营养不良蛋白肌动蛋白结合域突变的功能矫正。

Functional correction of dystrophin actin binding domain mutations by genome editing.

机构信息

Department of Molecular Biology.

Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center, and.

出版信息

JCI Insight. 2017 Sep 21;2(18). doi: 10.1172/jci.insight.95918.

DOI:10.1172/jci.insight.95918
PMID:28931764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5621913/
Abstract

Dystrophin maintains the integrity of striated muscles by linking the actin cytoskeleton with the cell membrane. Duchenne muscular dystrophy (DMD) is caused by mutations in the dystrophin gene (DMD) that result in progressive, debilitating muscle weakness, cardiomyopathy, and a shortened lifespan. Mutations of dystrophin that disrupt the amino-terminal actin-binding domain 1 (ABD-1), encoded by exons 2-8, represent the second-most common cause of DMD. In the present study, we compared three different strategies for CRISPR/Cas9 genome editing to correct mutations in the ABD-1 region of the DMD gene by deleting exons 3-9, 6-9, or 7-11 in human induced pluripotent stem cells (iPSCs) and by assessing the function of iPSC-derived cardiomyocytes. All three exon deletion strategies enabled the expression of truncated dystrophin protein and restoration of cardiomyocyte contractility and calcium transients to varying degrees. We show that deletion of exons 3-9 by genomic editing provides an especially effective means of correcting disease-causing ABD-1 mutations. These findings represent an important step toward eventual correction of common DMD mutations and provide a means of rapidly assessing the expression and function of internally truncated forms of dystrophin-lacking portions of ABD-1.

摘要

肌营养不良蛋白通过将肌动蛋白细胞骨架与细胞膜连接来维持横纹肌的完整性。杜氏肌营养不良症(DMD)是由肌营养不良蛋白基因(DMD)的突变引起的,导致进行性、衰弱性肌肉无力、心肌病和寿命缩短。肌营养不良蛋白的突变破坏了由外显子 2-8 编码的氨基末端肌动蛋白结合域 1(ABD-1),这是 DMD 的第二大常见原因。在本研究中,我们比较了三种不同的 CRISPR/Cas9 基因组编辑策略,以通过删除人诱导多能干细胞(iPSC)中的 DMD 基因 ABD-1 区的外显子 3-9、6-9 或 7-11,从而纠正 ABD-1 区的突变,并评估 iPSC 衍生的心肌细胞的功能。所有三种外显子缺失策略都能够表达截断的肌营养不良蛋白,并在不同程度上恢复心肌细胞的收缩性和钙瞬变。我们表明,通过基因组编辑删除外显子 3-9 提供了纠正致病 ABD-1 突变的特别有效手段。这些发现代表了朝着最终纠正常见 DMD 突变迈出的重要一步,并提供了一种快速评估 ABD-1 缺失内部截断形式的表达和功能的方法。

相似文献

1
Functional correction of dystrophin actin binding domain mutations by genome editing.基因组编辑对肌营养不良蛋白肌动蛋白结合域突变的功能矫正。
JCI Insight. 2017 Sep 21;2(18). doi: 10.1172/jci.insight.95918.
2
Restoration of Dystrophin Protein Expression by Exon Skipping Utilizing CRISPR-Cas9 in Myoblasts Derived from DMD Patient iPS Cells.利用CRISPR-Cas9通过外显子跳跃恢复来自杜氏肌营养不良症(DMD)患者诱导多能干细胞(iPS细胞)的成肌细胞中肌营养不良蛋白的表达。
Methods Mol Biol. 2018;1828:191-217. doi: 10.1007/978-1-4939-8651-4_12.
3
Correction of Three Prominent Mutations in Mouse and Human Models of Duchenne Muscular Dystrophy by Single-Cut Genome Editing.通过单切基因组编辑纠正杜氏肌营养不良症小鼠和人类模型中的三个突出突变。
Mol Ther. 2020 Sep 2;28(9):2044-2055. doi: 10.1016/j.ymthe.2020.05.024. Epub 2020 May 30.
4
A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells.一种针对大多数杜氏肌营养不良症(DMD)患者的单一CRISPR-Cas9缺失策略可恢复人诱导多能干细胞(hiPSC)衍生的肌肉细胞中的肌营养不良蛋白功能。
Cell Stem Cell. 2016 Apr 7;18(4):533-40. doi: 10.1016/j.stem.2016.01.021. Epub 2016 Feb 11.
5
Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9.利用 TALEN 和 CRISPR-Cas9 精确校正杜氏肌营养不良症患者诱导多能干细胞中的肌营养不良蛋白基因。
Stem Cell Reports. 2015 Jan 13;4(1):143-154. doi: 10.1016/j.stemcr.2014.10.013. Epub 2014 Nov 26.
6
Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing.碱基编辑和先导编辑精确校正杜氏肌营养不良症外显子缺失突变。
Sci Adv. 2021 Apr 30;7(18). doi: 10.1126/sciadv.abg4910. Print 2021 Apr.
7
CRISPR/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human gene.CRISPR/Cas9 基因编辑技术构建的杜氏肌营养不良症小鼠模型,可重现人类基因中一个新鉴定的 430kb 大片段缺失。
Dis Model Mech. 2019 Apr 25;12(4):dmm037655. doi: 10.1242/dmm.037655.
8
CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells.CRISPR-Cas9 纠正了小鼠和人细胞中杜氏肌营养不良症外显子 44 缺失突变。
Sci Adv. 2019 Mar 6;5(3):eaav4324. doi: 10.1126/sciadv.aav4324. eCollection 2019 Mar.
9
Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy.体细胞基因编辑改善了杜氏肌营养不良症猪和人类模型的骨骼肌和心肌衰竭。
Nat Med. 2020 Feb;26(2):207-214. doi: 10.1038/s41591-019-0738-2. Epub 2020 Jan 27.
10
In vivo genome editing in mouse restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers.体内基因编辑技术在小鼠中修复杜氏肌营养不良症患者肌纤维中的肌营养不良蛋白表达。
Genome Med. 2021 Apr 12;13(1):57. doi: 10.1186/s13073-021-00876-0.

引用本文的文献

1
Transcriptomic profiling of skeletal muscle in the DMD rat model of Duchenne muscular dystrophy.杜兴氏肌营养不良症DMD大鼠模型中骨骼肌的转录组分析
Sci Rep. 2025 Aug 11;15(1):29312. doi: 10.1038/s41598-025-14756-9.
2
Biosafety considerations triggered by genome-editing technologies.基因组编辑技术引发的生物安全考量。
Biosaf Health. 2025 May 13;7(3):141-151. doi: 10.1016/j.bsheal.2025.05.003. eCollection 2025 Jun.
3
Mechanically and Chemically Defined PEG Hydrogels Improve Reproducibility in Human Cardioid Development.机械和化学定义的聚乙二醇水凝胶提高了人类心脏发育研究的可重复性。
Adv Healthc Mater. 2025 Jun;14(16):e2403997. doi: 10.1002/adhm.202403997. Epub 2025 May 16.
4
Gene Editing for Duchenne Muscular Dystrophy: From Experimental Models to Emerging Therapies.杜氏肌营养不良症的基因编辑:从实验模型到新兴疗法
Degener Neurol Neuromuscul Dis. 2025 Apr 12;15:17-40. doi: 10.2147/DNND.S495536. eCollection 2025.
5
Antisense oligonucleotides and their applications in rare neurological diseases.反义寡核苷酸及其在罕见神经系统疾病中的应用。
Front Neurosci. 2024 Sep 23;18:1414658. doi: 10.3389/fnins.2024.1414658. eCollection 2024.
6
Comprehensive review of adverse reactions and toxicology in ASO-based therapies for Duchenne Muscular Dystrophy: From FDA-approved drugs to peptide-conjugated ASO.杜氏肌营养不良症基于反义寡核苷酸疗法的不良反应与毒理学综合综述:从美国食品药品监督管理局批准的药物到肽缀合反义寡核苷酸
Curr Res Toxicol. 2024 Jun 18;7:100182. doi: 10.1016/j.crtox.2024.100182. eCollection 2024.
7
Physiological stress improves stem cell modeling of dystrophic cardiomyopathy.生理应激改善营养不良性心肌病的干细胞建模。
Dis Model Mech. 2024 Jun 1;17(6). doi: 10.1242/dmm.050487. Epub 2024 Feb 5.
8
Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in actin binding domain 1.外显子跳跃疗法对肌动蛋白结合结构域1发生突变的杜氏肌营养不良症心肌病的疗效。
Mol Ther Nucleic Acids. 2023 Oct 19;34:102060. doi: 10.1016/j.omtn.2023.102060. eCollection 2023 Dec 12.
9
Recent Advances in CRISPR/Cas9 Delivery Approaches for Therapeutic Gene Editing of Stem Cells.CRISPR/Cas9 递送方法在干细胞治疗性基因编辑中的最新进展。
Stem Cell Rev Rep. 2023 Nov;19(8):2576-2596. doi: 10.1007/s12015-023-10585-3. Epub 2023 Sep 18.
10
CRISPR-Cas9 correction in the DMD mouse model is accompanied by upregulation of Dp71f protein.在杜氏肌营养不良症(DMD)小鼠模型中,CRISPR-Cas9基因编辑伴随着Dp71f蛋白的上调。
Mol Ther Methods Clin Dev. 2023 Jun 17;30:161-180. doi: 10.1016/j.omtm.2023.06.006. eCollection 2023 Sep 14.

本文引用的文献

1
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System.利用单一CRISPR/Cas9系统纠正杜氏肌营养不良症成肌细胞中的外显子2重复
Mol Ther Nucleic Acids. 2017 Jun 16;7:11-19. doi: 10.1016/j.omtn.2017.02.004. Epub 2017 Feb 10.
2
Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.使用CRISPR/Cas9对人类诱导多能干细胞进行基因编辑和克隆分离
Methods. 2017 May 15;121-122:29-44. doi: 10.1016/j.ymeth.2017.05.009.
3
Creation of a Novel Humanized Dystrophic Mouse Model of Duchenne Muscular Dystrophy and Application of a CRISPR/Cas9 Gene Editing Therapy.创建新型人源化杜氏肌营养不良症模型鼠及 CRISPR/Cas9 基因编辑疗法的应用。
J Neuromuscul Dis. 2017;4(2):139-145. doi: 10.3233/JND-170218.
4
CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice.CRISPR-Cpf1 纠正人类心肌细胞和小鼠中的肌肉营养不良突变。
Sci Adv. 2017 Apr 12;3(4):e1602814. doi: 10.1126/sciadv.1602814. eCollection 2017 Apr.
5
Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy.多肽偶联型多外显子跳跃反义寡核苷酸在杜氏肌营养不良症犬模型心脏中的作用。
Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4213-4218. doi: 10.1073/pnas.1613203114. Epub 2017 Apr 3.
6
Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy.肌肉特异性 CRISPR/Cas9 肌营养不良蛋白基因编辑改善杜氏肌营养不良症小鼠模型的病理生理学。
Nat Commun. 2017 Feb 14;8:14454. doi: 10.1038/ncomms14454.
7
Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.具有高级成熟度的定制工程化人类心肌,用于心力衰竭建模与修复应用。
Circulation. 2017 May 9;135(19):1832-1847. doi: 10.1161/CIRCULATIONAHA.116.024145. Epub 2017 Feb 6.
8
Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.人类诱导多能干细胞作为个性化精准心血管医学的一个平台
Physiol Rev. 2016 Jul;96(3):1093-126. doi: 10.1152/physrev.00036.2015.
9
Deletion of exons 3-9 encompassing a mutational hot spot in the DMD gene presents an asymptomatic phenotype, indicating a target region for multiexon skipping therapy.缺失包含DMD基因中一个突变热点的外显子3至9呈现无症状表型,表明这是多外显子跳跃疗法的一个靶区域。
J Hum Genet. 2016 Jul;61(7):663-7. doi: 10.1038/jhg.2016.28. Epub 2016 Mar 24.
10
A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells.一种针对大多数杜氏肌营养不良症(DMD)患者的单一CRISPR-Cas9缺失策略可恢复人诱导多能干细胞(hiPSC)衍生的肌肉细胞中的肌营养不良蛋白功能。
Cell Stem Cell. 2016 Apr 7;18(4):533-40. doi: 10.1016/j.stem.2016.01.021. Epub 2016 Feb 11.